US Patent Issued to Quest Diagnostics Investments Incoporated on Dec. 9 for "Quantitation of insulin-like growth factor-I and insulin-like growth factor-II with high-resolution mass spectrometry" (California, Ohio Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,493,049, issued on Dec. 9, was assigned to Quest Diagnostics Investments Incoporated (Secaucus, N.J.).

"Quantitation of insulin-like growth factor-I and insulin-like growth factor-II with high-resolution mass spectrometry" was invented by Cory Bystrom (Beachwood, Ohio), Shijun Sheng (Las Flores, Calif.), Nigel Clarke (Vista, Calif.) and Richard Reitz (San Clemente, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of determining the amount of an IGF-I and/or IGF-II protein in a sample using high resolution/high accuracy mass spectrometry includes enriching an IGF-I and/or IGF-II protein in a sample, ionizing an IGF-I and/or IGF-II protein fr...